<DOC>
	<DOCNO>NCT00624390</DOCNO>
	<brief_summary>The purpose research study obtain preliminary data safety effectiveness Sepraspray limit number patient go laparoscopic myomectomy . Sepraspray apply organ pelvic cavity follow laparoscopic myomectomy . We compare treatment Sepraspray adhesion prevention barrier laparoscopic myomectomy versus adhesion barrier .</brief_summary>
	<brief_title>Seprasprayâ„¢ Laparoscopic Myomectomy Study</brief_title>
	<detailed_description />
	<criteria>The patient must premenopausal woman myomas associate clinical symptom deem suitable laparoscopic myomectomy SLL . Pregnant/lactating woman . The patient history hypersensitivity exogenous carboxymethylcellulose product and/or hyaluronic acid . The patient 's procedure result entry endometrial cavity , entry bowel include appendectomy .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>